• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中固有免疫细胞及其与T细胞的相互作用。

Innate immune cells and their interaction with T cells in hepatocellular carcinoma.

作者信息

Hong Guo-Qing, Cai Dong, Gong Jian-Ping, Lai Xing

机构信息

Department of Hepatobiliary and Thyroid Breast Surgery, Tongnan District People's Hospital, Chongqing 402660, P.R. China.

Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China.

出版信息

Oncol Lett. 2021 Jan;21(1):57. doi: 10.3892/ol.2020.12319. Epub 2020 Nov 19.

DOI:10.3892/ol.2020.12319
PMID:33281968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709558/
Abstract

Hepatocellular carcinoma (HCC) is a malignant tumor and is associated with necroinflammation driven by various immune cells, such as dendritic cells, macrophages and natural killer cells. Innate immune cells can directly affect HCC or regulate the T-cell responses that mediate HCC. In addition, innate immune cells and T cells are not isolated, which means the interaction between them is important in the HCC microenvironment. Considering the current unsatisfactory efficacy of immunotherapy in patients with HCC, understanding the relationship between innate immune cells and T cells is necessary. In the present review the roles and clinical value of innate immune cells that have been widely reported to be involved in HCC, including dendritic cells, macrophages (including kupffer cells), neutrophils, eosinophils, basophils and innate lymphoid cells and the crosstalk between the innate and adaptive immune responses in the antitumor process have been discussed. The present review will facilitate researchers in understanding the importance of innate immune cells in HCC and lead to innovative immunotherapy approaches for the treatment of HCC.

摘要

肝细胞癌(HCC)是一种恶性肿瘤,与由多种免疫细胞(如树突状细胞、巨噬细胞和自然杀伤细胞)驱动的坏死性炎症相关。固有免疫细胞可直接影响HCC或调节介导HCC的T细胞反应。此外,固有免疫细胞和T细胞并非孤立存在,这意味着它们之间的相互作用在HCC微环境中很重要。鉴于目前HCC患者免疫治疗的疗效不尽人意,了解固有免疫细胞与T细胞之间的关系很有必要。在本综述中,讨论了广泛报道的参与HCC的固有免疫细胞的作用和临床价值,包括树突状细胞、巨噬细胞(包括库普弗细胞)、中性粒细胞、嗜酸性粒细胞、嗜碱性粒细胞和固有淋巴细胞,以及抗肿瘤过程中固有免疫反应和适应性免疫反应之间的相互作用。本综述将有助于研究人员了解固有免疫细胞在HCC中的重要性,并为HCC的治疗带来创新的免疫治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cce/7709558/41cf98772296/ol-21-01-12319-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cce/7709558/4a5e4b80b5b0/ol-21-01-12319-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cce/7709558/41cf98772296/ol-21-01-12319-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cce/7709558/4a5e4b80b5b0/ol-21-01-12319-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cce/7709558/41cf98772296/ol-21-01-12319-g01.jpg

相似文献

1
Innate immune cells and their interaction with T cells in hepatocellular carcinoma.肝细胞癌中固有免疫细胞及其与T细胞的相互作用。
Oncol Lett. 2021 Jan;21(1):57. doi: 10.3892/ol.2020.12319. Epub 2020 Nov 19.
2
Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities.重塑基于固有或固有样免疫细胞的肝细胞癌治疗策略:新的机制见解和先进的机遇。
Med Oncol. 2023 Jan 21;40(2):84. doi: 10.1007/s12032-023-01948-4.
3
Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.树突状细胞衍生的外泌体在同源性肝细胞肝癌小鼠模型中引发肿瘤消退。
J Hepatol. 2017 Oct;67(4):739-748. doi: 10.1016/j.jhep.2017.05.019. Epub 2017 May 24.
4
Immunology of hepatocellular carcinoma.肝细胞癌的免疫学
World J Hepatol. 2015 Aug 18;7(17):2080-90. doi: 10.4254/wjh.v7.i17.2080.
5
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.唑来膦酸可增强肝癌细胞对Vγ9Vδ2 T淋巴细胞介导杀伤的敏感性。
Int J Oncol. 2016 May;48(5):1794-804. doi: 10.3892/ijo.2016.3403. Epub 2016 Feb 19.
6
CD8 T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma.CD8 T 细胞介导乳香和没药在肝细胞癌中的抗肿瘤活性。
J Transl Med. 2018 May 21;16(1):132. doi: 10.1186/s12967-018-1508-5.
7
The role of the innate immune system in the development and treatment of hepatocellular carcinoma.先天免疫系统在肝细胞癌发生发展及治疗中的作用
Hepat Oncol. 2020 Jan 31;7(1):HEP17. doi: 10.2217/hep-2019-0007.
8
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma.肝细胞癌治疗中免疫抑制细胞的解读与逆转
J Liver Cancer. 2020 Mar;20(1):1-16. doi: 10.17998/jlc.20.1.1. Epub 2020 Mar 31.
9
T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.肝细胞癌免疫微环境中的T淋巴细胞:对人类免疫学和免疫治疗的见解
Am J Cancer Res. 2020 Dec 1;10(12):4585-4606. eCollection 2020.
10
HEPATOCELLULAR CARCINOMA: CURRENT AND PROSPECTIVE IMMUNOTHERAPEUTIC STRATEGIES.肝细胞癌:当前及未来的免疫治疗策略
Georgian Med News. 2015 Sep(246):78-84.

引用本文的文献

1
From "Traditional" to "Trained" Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).从“传统”免疫到“训练有素”的免疫:探索代谢功能障碍相关脂肪性肝病(MASLD)进展中免疫发病机制的新前沿
Biomedicines. 2025 Aug 18;13(8):2004. doi: 10.3390/biomedicines13082004.
2
Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis.接受根治性治疗的肝细胞癌患者中性粒细胞与淋巴细胞比值的预后价值:一项系统评价和荟萃分析
BMC Cancer. 2025 Mar 29;25(1):571. doi: 10.1186/s12885-025-13972-w.
3

本文引用的文献

1
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update.肝细胞癌的免疫治疗:2021年最新进展
Cancers (Basel). 2020 Oct 4;12(10):2859. doi: 10.3390/cancers12102859.
2
Nanoparticle Delivery of MnO and Antiangiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma.纳米颗粒递送 MnO 和抗血管生成治疗以克服缺氧驱动的肿瘤逃逸并抑制肝细胞癌。
ACS Appl Mater Interfaces. 2020 Oct 7;12(40):44407-44419. doi: 10.1021/acsami.0c08473. Epub 2020 Sep 28.
3
Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies.
Mutual causal effects between immune cells and hepatocellular carcinoma: a Mendelian randomization study.
免疫细胞与肝细胞癌之间的相互因果关系:一项孟德尔随机化研究。
Discov Oncol. 2025 Jan 16;16(1):54. doi: 10.1007/s12672-025-01785-z.
4
Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma.在肝细胞癌中鉴定以独特微环境为特征的免疫细胞相关预后基因。
World J Clin Oncol. 2024 Feb 24;15(2):243-270. doi: 10.5306/wjco.v15.i2.243.
5
Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.上调的 CANT1 与肝癌的不良预后相关。
BMC Cancer. 2023 Oct 19;23(1):1007. doi: 10.1186/s12885-023-11463-4.
6
Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma.关于细胞因子区室化谱在肝细胞癌风险中的作用的研究。
Int J Mol Sci. 2023 Aug 30;24(17):13432. doi: 10.3390/ijms241713432.
7
Exploring the Regulatory Role of XIST-microRNAs/mRNA Network in Circulating CD4 T Cells of Hepatocellular Carcinoma Patients.探索XIST-微小RNA/信使核糖核酸网络在肝癌患者循环CD4 T细胞中的调控作用。
Biomedicines. 2023 Jun 27;11(7):1848. doi: 10.3390/biomedicines11071848.
8
Ablation of Tumor Necrosis Factor Alpha Receptor 1 Signaling Blunts Steatohepatitis in Peroxisome Proliferator Activated Receptor α-Deficient Mice.肿瘤坏死因子α受体1信号通路的消融可减轻过氧化物酶体增殖物激活受体α缺陷小鼠的脂肪性肝炎。
Med Res Arch. 2022 Oct;10(9). doi: 10.18103/mra.v10i9.3082. Epub 2022 Sep 20.
9
Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma.预后不良生物标志物KIAA1522与肝细胞癌中的免疫浸润相关。
J Oncol. 2023 Jan 31;2023:3538928. doi: 10.1155/2023/3538928. eCollection 2023.
10
Viral Hepatitis and Hepatocellular Carcinoma: State of the Art.病毒性肝炎与肝细胞癌:最新进展
Pathogens. 2021 Oct 22;10(11):1366. doi: 10.3390/pathogens10111366.
肝细胞癌的肿瘤内异质性:从单细胞到基于群体的研究。
World J Gastroenterol. 2020 Jul 14;26(26):3720-3736. doi: 10.3748/wjg.v26.i26.3720.
4
Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect.肝细胞癌微环境中的糖代谢重编程:因果关系
Cancer Manag Res. 2020 Jul 17;12:5957-5974. doi: 10.2147/CMAR.S258196. eCollection 2020.
5
A new dawn for eosinophils in the tumour microenvironment.肿瘤微环境中嗜酸性粒细胞的新曙光。
Nat Rev Cancer. 2020 Oct;20(10):594-607. doi: 10.1038/s41568-020-0283-9. Epub 2020 Jul 16.
6
LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells.长链非编码RNA FTX通过调节枯否细胞的M1/M2极化来抑制非酒精性脂肪性肝病向肝细胞癌的进展。
Cancer Cell Int. 2020 Jun 24;20:266. doi: 10.1186/s12935-020-01354-0. eCollection 2020.
7
Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma.与肝细胞癌预后和免疫治疗反应相关的微环境特征及多组学特征
Exp Hematol Oncol. 2020 May 25;9:10. doi: 10.1186/s40164-020-00165-3. eCollection 2020.
8
Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity.肝细胞癌的遗传学:探索分子多样性的方法
Hepatology. 2021 Jan;73 Suppl 1:14-26. doi: 10.1002/hep.31394. Epub 2020 Dec 8.
9
Innate immune cells in cirrhosis.肝硬化中的固有免疫细胞。
J Hepatol. 2020 Jul;73(1):186-201. doi: 10.1016/j.jhep.2020.03.027. Epub 2020 Mar 30.
10
Macrophage Phenotype and Function in Liver Disorder.肝疾病中巨噬细胞的表型与功能
Front Immunol. 2020 Jan 28;10:3112. doi: 10.3389/fimmu.2019.03112. eCollection 2019.